Atlas Trials

NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma

Clinical trial NCT02805894 · TERMINATED

Trial details

NCT number
NCT02805894
Sponsor
Nanobiotix
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2017-11-15
Primary completion
2020-03-19
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.